Calls Purchased on Alkermes, Inc.

Shares of Alkermes, Inc. ALKS are higher on the session by 2.29%, currently trading at $18.54. The stock has been moving largely higher over the past four months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A short while ago the December $5.00 call was purchased ~3,000 times, on the offer, on open interest of only 427 contracts. This signals new positioning on the strike. Overall call volume is now running at 2.66x the daily average with 84% of all calls traded being purchases on the offer. Alkermes, Inc. is an integrated biotechnology company. The company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases.